Drug Information Related to Kepivance
Back
01. BRIEFCASE JANITORS WALK OUT AT TWO HOSPITALS. - Free Online Library...
Byline: - Staff and Wire Services
Hundreds of janitors walked off their jobs Wednesday at Olive View
Medical Center in Sylmar and at Harbor/UCLA Medical Center.
They are seeking higher wages. Their pay, $8.32 an hour, is set by
the county's living wage ordin...
02. Stock buyback, patent victory give bounce to Amgen shares. - Free ......
JUST a year ago, Amgen Inc, took a beating from analysts and the
media. Not only did the Thousand Oaks-based biotech giant have a weak
drug pipeline, but the government's attempt to reign in
skyrocketing health care costs, specifically for cancer drugs, was
expect...
03. Amgen Names Jim Daly, Senior Vice President, North America Commercial ...
THOUSAND OAKS, Calif. -- Amgen Inc. (NASDAQ:AMGN), the world's
largest biotechnology company, today announced the appointment of Jim
Daly to the new position of senior vice president, North America
Commercial Operations. Daly, formerly vice president and general ...
04. Amgen's First Quarter 2005 Adjusted Earnings Per Share Increased 26 .....
THOUSAND OAKS, Calif. -- Amgen Inc. (NASDAQ:AMGN):--First Quarter 2005 GAAP Earnings Per Share of 67 Cents--Total Product Sales Increased 24 Percent--2005 Guidance Increased for Total Revenue and Adjusted EPSAmgen Inc. (NASDAQ:AMGN), the world's largest biotechnology
...
05. Amgen's Third Quarter 2005 Adjusted Earnings Per Share Increased 33 .....
THOUSAND OAKS, Calif. -- Third Quarter Product Sales Growth of 19
Percent Driven by Sales of Aranesp, Neulasta and Enbrel En·brel (nbrlAmgen (NASDAQ:AMGN) reported adjusted earnings per share (EPS) of
85 cents for the third quarter of 2005, an increase of 33 p...
06. Amgen's Fourth Quarter 2005 Adjusted Earnings Per Share Increased 29 ....
THOUSAND OAKS, Calif. -- Amgen (NASDAQ:AMGN):--Fourth Quarter 2005 GAAP Earnings Per Share Increased to 66 Cents
from 53 Cents; Full Year 2005 GAAP Earnings Per Share of $2.93--2006 Total Revenue Expected to be in the Range of $13.9 to $14.4
Billion--2006 Adjusted E...
07. Lawsuit Charges Insurance Companies, Financial Planners With Elder ......
SAN FRANCISCO -- Two Bay Area senior citizens organizations have announced that a consumer protection lawsuit they filed in October in San Francisco Superior Court puts annuities companies on notice to end unfair marketing to seniors. The lawsuit charges two insuran...
08. Pharmaceutical: top 50 packages | Food & Drug Packaging | Find Art...
PHARMACEUTICAL
TOP 50 PACKAGERS
Rank Company Total Revenues
(last year) Headquarters (in $ Millions)
1 Pfizer Inc. 52,500.0
(1) New York, N.Y.
2 GIaxoSmithKline plc ...
09. Amgen's Kepivance approved by FDA for severe oral mucositis in cancer ...
Amgen, Inc., Thousand Oaks, CA, announced the US Food and Drug Administration (FDA) has approved Kepivance (palifermin), the first and only therapy to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients with hematologic cancers under...
10. New drug to treat cancer-related mouth sores | FDA Consumer | Find ......
Painful sores and ulcers in the lining of the mouth are a common complication of the high-dose chemotherapy and radiation therapy regimens associated with bone marrow transplants. Patients suffering from the complication, called mucositis, have difficulty eating and s...
11. Palifermin reduces incidence and duration of severe mucositis | Journa...
The FDA approved palifermin (Kepivance, made by Amgen, Inc.) for the treatment of severe oral mucositis in patients with hematologic malignancies undergoing chemotherapy with or without radiation. It is the first drug to be FDA-approved for this indication. Palifermin...
12. Reyataz, Lunesta Win MM&M Gold Awards | Business Wire | Find Artic...
NEW YORK -- The marketers behind Reyataz and Lunesta took top honors at the MM&M Awards 2005.
...
